This site contains promotional information intended only for healthcare professionals resident in the United Kingdom

Search
Menu
Close
Sign In or RegisterLog Out
Pfizer MedicinesTherapy AreasExplore ContentEventsVideosMaterialsLet’s ConnectSupplyAlliance HealthcareOff-contract claims

Example content

Adverse event reporting can be found at the bottom of the page

You are now leaving PfizerPro You are now leaving www.pfizerpro.co.uk and will be directed to our provider, Vistream, to complete your registration. Any personal information that you may find pre-populated from your PfizerPro profile, or you may provide, will be governed by our Privacy Policy. Your data will not be used by Vistream for any other purpose.

PP-UNP-GBR-5079. June 2023
Understanding the Role of the Clinical Nurse Specialist (CNS) in Suspicion, Diagnosis and Treatment of ATTR-CM

Prescribing information can be found at the bottom of the page. 


Join us on 22 January 2026 to hear from Angelique Smit, Senior Lead Clinical Nurse Specialist and Carys Barton, Heart Failure Nurse Consultant  discussing 'Understanding the Role of the Clinical Nurse Specialist (CNS) in Suspicion, Diagnosis and Treatment of ATTR-CM' followed by a live interactive Q&A.

This promotional meeting is organised and funded by Pfizer Ltd for UK HCPs and will include reference to medicines promoted by Pfizer. 

This meeting is available to join virtually.  There will be local HCPs attending in-person and no travel or accommodation costs will be supported to attend this meeting.

Prescribing information can be found at the bottom of the page. 


Join us on 22 January 2026 to hear from Angelique Smit, Senior Lead Clinical Nurse Specialist and Carys Barton, Heart Failure Nurse Consultant  discussing 'Understanding the Role of the Clinical Nurse Specialist (CNS) in Suspicion, Diagnosis and Treatment of ATTR-CM' followed by a live interactive Q&A.

This promotional meeting is organised and funded by Pfizer Ltd for UK HCPs and will include reference to medicines promoted by Pfizer. 

This meeting is available to join virtually.  There will be local HCPs attending in-person and no travel or accommodation costs will be supported to attend this meeting.

Event Date22 January 2026 18:30 GMTDuration1 Hr 5 AudienceNurses {{givenName}}%20{{familyName}}%20has%20shared%20a%20resource%20with%20you%3B%20please%20click%20the%20link%20below%3A%0D%0A%0D%0A{{URL}}%0D%0A%0D%0AThank%20you%2C%0D%0A{{givenName}}%20{{familyName}}
Agenda
Meeting Agenda 18:15 - 18:30Arrival, Joining & Registration
18:30 - 18:35Welcome & Introduction Katherine O'Hara, Pfizer Ltd
18:35 - 18:55ATTR-CM: From Early Detection to Diagnosis and Treatment access – a NAC Expert’s Perspective Angelique Smit
18:55 - 19:05Questions & Answers Angelique Smit
19:05 - 19:25Understanding the Role of the Clinical Nurse Specialist (CNS) in Suspicion, Diagnosis and Treatment of ATTR-CM Carys Barton
19:25 - 19:35Questions & Answers Carys Barton
19:35Meeting close
Speakers
Event Speakers
Angelique Smit
Angelique SmitSenior Lead Clinical Nurse Specialist , National Amyloidosis Centre

No Biography Available.

Carys Barton
Carys BartonHeart Failure Nurse Consultant, Imperial College Healthcare NHS Trust

No Biography Available

Vyndaqel®(tafamidis) 

Prescribing Information

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or search for MHRA Yellow Card in Google Play or Apple App Store. Adverse events should also be reported to Pfizer Medical Information on 01304 616161.

PP-VYN-GBR-2895. December 2025

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or search 

for MHRA Yellow Card in Google Play or Apple App Store

 

Adverse events should also be reported to Pfizer Medical Information on 01304 616161

PfizerPro Account

To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.

Sign In or RegisterAccountSign Out

This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc

 

This website is brought to you by Pfizer Limited, a company registered in England 

and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ

 

Copyright © 2026 Pfizer Limited. All rights reserved.

 

VAT registration number GB201048427

PP-UNP-GBR-13934. January 2026
For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-UNP-GBR-13971. December 2025

YesNo
You are now leaving PfizerPro​​​​​

You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned nor controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site.

PP-UNP-GBR-12070. April 2025​​​​​​​
​​​​​​​
You are now leaving PfizerPro

​​​​​​​You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned nor controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site other than the information or other materials relating to ​​​​​Pfizer's medicines or business which it has provided or reviewed.

PP-UNP-GBR-12107. April 2025
​​​​​​​